With the new incorporation, the company consolidates its transition from a software business to an AI-driven biotech company. Barcelona, 6 October 2020 – Chemotargets, a global leader in predictive analytics…
Read More
This public-private partnership will establish a framework for collaboration that promotes the creation of synergies between both institutions. Chemotargets has entered into a strategic alliance with the IMIM Hospital del…
The Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) has licensed the Chemotargets CLARITY® platform for predicting unknown secondary targets for new molecules of pharmaceutical interest….
GENESIS Biomed and CREA Inversión will advise in the funding, which will allow the company to expand its activity in the discovery of new drugs. Barcelona, 14 April 2020 –…
PS: SOT conference has been canceled due to the global situation regarding COVID-19 Chemotargets will participate at the Society of Toxicology Annual meeting (SOT2020) in Anaheim, California (US), March 15-19,…
Updates on data and models, and a new explorer module to navigate by scaffolds and molecules related data, the MedChem Explorer. This month, we are pleased to announce the launch…
The Seal of Excellence certifies the high-quality of the CLARITY proposal aimed at enhancing its data coverage, artificial intelligence approaches and analytics tools for drug discovery. Barcelona, July 11th, 2019….
Chemotargets was presenting CLARITYⓇ v3.0 and the new features of v4.0 at three international audience conferences: 17-20th June 2019 – World Pharma Week, Boston (US) https://www.pharmaweek.com/ 26-28th June 2019 –…
Visit us at stand number P132 Chemotargets will be First time Exhibitor at the in-cosmetics Global event, which will take place on the 2nd-4th April 2019 in Paris (France). We…
Join us at booth number 4210 Chemotargets will participate at the Society of Toxicology Annual meeting (SOT2019) in Baltimore, MD, March 10-14, 2019. We will be present Chemotargets CLARITYⓇ, the…
